Showing results (51-60 of 183) with videos related to

Sort By:
Pageof 19
Blood|August 9, 2011
Bcr-abl signals to desensitize chronic myeloid leukemia cells to IFNα via accelerating the degradation of its receptorSabyasachi Bhattacharya, Hui Zheng, Christos Tzimas, et al.
Health Policy (Amsterdam, Netherlands)|June 24, 2021
Common patterns in the public reporting of waiting time and waiting list information: Findings from a sample of OECD jurisdictionsMandy Lee, Margaret Martin-Carroll, Wendy von Mollendorff, et al.
Science Translational Medicine|April 3, 2015
Single-cell genotyping demonstrates complex clonal diversity in acute myeloid leukemiaAmy L Paguirigan, Jordan Smith, Soheil Meshinchi, et al.
Journal of the American Academy of Dermatology|November 7, 2017
Sweet syndrome in patients with and without malignancy: A retrospective analysis of 83 patients from a tertiary academic referral centerCaroline A Nelson, Megan H Noe, Christine M McMahon, et al.
American Journal of Hematology|May 4, 2013
Receipt of maintenance therapy is most predictive of survival in older acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimensDaniel J Landsburg, Edward Stadtmauer, Alison Loren, et al.
Evolutionary Applications|February 12, 2013
An evolutionary explanation for the presence of cancer nonstem cells in neoplasmsKathleen Sprouffske, C Athena Aktipis, Jerald P Radich, et al.
Blood|June 8, 2018
Phase 2b study of 2 dosing regimens of quizartinib monotherapy in FLT3-ITD-mutated, relapsed or refractory AMLJorge E Cortes, Martin S Tallman, Gary J Schiller, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 5, 2025
Advancing the Management of CH, MDS, and AML From the First Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma ConferenceHetty E Carraway, Andrew M Brunner, Catherine E Lai, et al.
Blood Advances|April 13, 2018
A next-generation sequencing-based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutationsMark J Levis, Alexander E Perl, Jessica K Altman, et al.
Experimental Hematology|July 22, 2010
Interferon regulatory factor-8-driven myeloid differentiation is regulated by 12/15-lipoxygenase-mediated redox signalingMichelle Kinder, James E Thompson, Cong Wei, et al.
Pageof 19